1)Lenneman CG, Sawyer DB : Cardio-Oncology : An Update on Cardiotoxicity of Cancer-Related Treatment. Circ Res 118:1008-1020,2016
2)Barac A, Murtagh G, Carver JR, et al : Cardiovascular Health of Patients With Cancer and Cancer Survivors : A Roadmap to the Next Level. J Am Coll Cardiol 65:2739-2746,2015
3)Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al : 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines : The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 37:2768-2801,2016
4)日本臨床腫瘍学会(編):がん免疫療法ガイドライン,第2版.金原出版,2019
5)Johnson DB, Balko JM, Compton ML, et al : Fulminant Myocarditis with Combination Immune Checkpoint Blockade. N Engl J Med 375:1749-1755,2016
6)Groarke JD, Nguyen PL, Nohria A, et al : Cardiovascular complications of radiation therapy for thoracic malignancies : the role for non-invasive imaging for detection of cardiovascular disease. Eur Heart J 35:612-623,2014
7)Yeh ET, Bickford CL : Cardiovascular complications of cancer therapy : incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol 53:2231-2247,2009
8)Pandey AK, Singhi EK, Arroyo JP, et al : Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease. Hypertension 71:e1-e8,2018
9)Varki A : Trousseau's syndrome : multiple definitions and multiple mechanisms. Blood 110:1723-1729,2007
10)Ay C, Pabinger I, Cohen AT : Cancer-associated venous thromboembolism : Burden, mechanisms, and management. Thromb Haemost 117:219-230,2017